The Gut as a Source of Inflammation in Chronic Kidney Disease
about
Vascular calcification: When should we interfere in chronic kidney disease patients and how?Stop chronic kidney disease progression: Time is approachingPatients with chronic kidney disease have abnormal upper gastro-intestinal tract digestive function: A study of uremic enteropathy.The effect of swimming exercise on adenine-induced kidney disease in rats, and the influence of curcumin or lisinopril thereon.Dietary Metabolites and Chronic Kidney Disease.Toxins, Toxicity, and Endotoxemia: A Historical and Clinical Perspective for Chiropractors.Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation.Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium studyL-Carnitine improves gastrointestinal disorders and altered the intestinal microbiota in hemodialysis patients.Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative reviewIntestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options.The Cerebrovascular-Chronic Kidney Disease Connection: Perspectives and Mechanisms.Could physical exercise help modulate the gut microbiota in chronic kidney disease?Health Benefits of Fiber Fermentation.Impact of Dietary Fibers on Nutrient Management and Detoxification Organs: Gut, Liver, and Kidneys.Spleen contributes significantly to increased circulating levels of fibroblast growth factor 23 in response to lipopolysaccharide-induced inflammation.Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis.Effects of end-stage renal disease and dialysis modalities on blood ammonia level.ISN Forefronts Symposium 2015: IgA Nephropathy, the Gut Microbiota, and Gut−Kidney Crosstalk.Nutritional therapy reduces protein carbamylation through urea lowering in chronic kidney disease.Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease.Pathophysiology and therapeutics of premature ageing in chronic kidney disease, with a focus on glycative stress.Editorial over the Many Faces of Vitamin D in Chronic Kidney Disease: from Mineral to Immune-Inflammatory Modulator.Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.Dietary tetrahydrocurcumin reduces renal fibrosis and cardiac hypertrophy in 5/6 nephrectomized rats.Inulin oligofructose attenuates metabolic syndrome in high-carbohydrate, high-fat diet-fed rats.Efficacy of Nutritional Interventions on Inflammatory Markers in Haemodialysis Patients: A Systematic Review and Limited Meta-Analysis.PROBIOTIC SUPPLEMENTATION IN TRAINED TROTTER HORSES: EFFECT ON BLOOD CLINICAL PATHOLOGY DATA AND URINE METABOLOMIC ASSESSED IN FIELD.Does inflammation affect outcomes in dialysis patients?Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation?Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and OutcomeChronic kidney disease
P2860
Q28071582-DB61CF10-0CFA-4BB5-BCD8-027EF6771678Q28078020-775C1FB3-DAFC-4F75-B5CE-81D5B16E504AQ31101542-E7370B01-575E-4B0B-B66D-BD4C043D667EQ33605803-D5E2CC53-8B13-4D81-A61C-BF6BAEFF9A0BQ33616732-54C4063D-7CD0-4001-A45C-682DD7857395Q36213950-0F746054-282F-41D3-BED2-23305E4A8C0FQ36318355-300F5C36-E94A-40E0-BBA1-35975E1665F7Q37263314-5A80359D-E1F4-487E-8E57-B429509C4BFBQ37634779-0B26BE7A-72B1-4235-B329-A80C45E9AE63Q37695914-7D10C729-9EEB-46CE-8471-EBB0FD267D63Q38757951-EAE846D6-7F8F-4B14-88AF-401421D1AA13Q38821293-D8B4E3A9-71DD-4E43-8410-1E9AAF8F484FQ38829608-B227D553-6C13-4890-AFF1-E1C0074248A5Q39076655-C41335A6-857E-4DB2-A3BC-2F9FC5C4BC70Q39111416-38EC32F8-54A5-45A0-ACA0-47FE04A41A77Q40478704-42E659BC-DBB0-426D-9E79-578D9B48263BQ46260769-B810647A-9278-4263-9795-5B9B1388EBFEQ46632759-7F7E0799-AF12-4A92-9FB6-F97952674501Q47140307-7E80BE8E-CBD4-42AD-876B-B284BBBCECAEQ47676591-4EB149DB-D567-4B6D-B6A3-D1C69FBC2A49Q47899492-19936143-95E4-4C2B-BF2D-71B2F51B11D8Q48199124-4C4DE471-C01B-41A3-9B88-27046C848406Q49607273-29043E50-5A3B-4DE7-93AB-769629AC056FQ50108575-B1709D71-7F5E-4A91-8D1E-2A52B60ABE40Q50318201-59F8DF40-FADC-404A-979F-B5A0028B02A7Q51276800-ACC36158-07B0-4BC4-8A55-26CF49DBE376Q51736055-BBE13E64-7F83-49D2-ABF4-56464B102678Q52578118-66B4979C-D8A9-462A-9BB8-2CF8F5CECDABQ52669320-C25241C8-332A-4B8A-9B4C-9DC3A3967B14Q55252106-A68DD022-B988-4933-974F-01F3FAFDB457Q57117487-4CEC553A-1644-449C-8C07-5A07B7561A67Q57701181-90C55A01-BFE8-490A-AED2-0049624CB1DA
P2860
The Gut as a Source of Inflammation in Chronic Kidney Disease
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
The Gut as a Source of Inflammation in Chronic Kidney Disease
@ast
The Gut as a Source of Inflammation in Chronic Kidney Disease
@en
The Gut as a Source of Inflammation in Chronic Kidney Disease
@nl
type
label
The Gut as a Source of Inflammation in Chronic Kidney Disease
@ast
The Gut as a Source of Inflammation in Chronic Kidney Disease
@en
The Gut as a Source of Inflammation in Chronic Kidney Disease
@nl
prefLabel
The Gut as a Source of Inflammation in Chronic Kidney Disease
@ast
The Gut as a Source of Inflammation in Chronic Kidney Disease
@en
The Gut as a Source of Inflammation in Chronic Kidney Disease
@nl
P2860
P3181
P356
P1476
The Gut as a Source of Inflammation in Chronic Kidney Disease
@en
P2093
Nosratola D. Vaziri
Wei Ling Lau
P2860
P3181
P356
10.1159/000381990
P407
P577
2015-01-01T00:00:00Z